Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases Posted on January 22, 2025 This week, the FDA expanded the approval of Johnson & Johnson’s ketamine-based nasal spray, Spravato.
CISA and US and International Partners Publish Guidance on Priority Considerations in Product Selection for OT Owners and Operators News Today, CISA—along with U.S. and international partners—released joint guidance Secure… rooter January 13, 2025 1 min read 0
Latvia Punishes Drunk Drivers by Donating Their Cars to Ukraine News Leer en español. Read more… rooter March 10, 2023 1 min read 0
What Is a ChatGPT Agent and How Small Businesses Can Use It to Save Time and Money News You’ve likely used ChatGPT to draft an email, brainstorm ideas,… rooter August 13, 2025 1 min read 0
The Forever Battery? World’s First Diamond Battery Promises Power for Thousands of Years News The concept could apply to a wide range of applications,… rooter December 10, 2024 1 min read 0